The global gastrointestinal stent market is anticipated to grow at a considerable CAGR of around 5.5% during the forecast period. Technological innovations in medical science are major drivers for the growth of the GI stent market in the forecast period. Research is going on to make more promising innovations that can tackle gastrointestinal issues in a safe way. More successful implants are prior commitments for market players. For instance, in July 2020, Endo GI Medical which is an Israeli company has received approval in the field of gastroenterology. This approval has been granted by the US Food and Drug Administration. Endo GI Medical has developed a stenting placement system. This technology is the first of its kind which involves the placement of two stents at the same time especially in the area of the bile duct which is connected to the pancreas. Insertion of two stents at the same time will reduce the danger of infections and other life-threatening conditions.
Browse the full report description of “Global Gastrointestinal Stent Market Size, Share & Trends Analysis Report by Product Type (Biliary Stent, Duodenal Stent, Colonic Stent, Pancreatic Stent, Esophageal Stent), By Technology Type (Anti Migratory Stent, Drug Eluting Stent, Radioactive Stent, Anti Reflux Stent, and Shape Modified Stent), By Material (Plastic Stent, Self-Expanding Metal Stent, Covered Self Expandable Metallic Stent, Biodegradable or Drug Eluting Stent) And By End-User (Hospital, Specialty Clinic and Ambulatory Surgical Center) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/gastrointestinal-stent-market
Inserting stents is essential when there are blockages in the body due to stones or tumors. In this case, there is a need for more than one stent so that passage can be kept open. There are times when the organ becomes hyper-stimulated and risk increases. In these cases, the insertion of simultaneous stents becomes a game-changer. GI stenting is a nonsurgical method that gives relief in gastrointestinal cancer. Stenting is more opted than other methods of upper GI recanalization which are YAG Laser ablation and argon plasma coagulation. Stenting has a high technical success rate (close to 90%) and there is no need for expensive equipment. For instance, in Dec 2021, FDA in the US gave approval to svelte medical systems to commercialize SLENDER IDS and DIRECT RX drug eluting stent. These stents are low profile and provide positive outcomes in complex cases of coronary artery disease.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By product type
o By technology type
o By material
o By end user
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Becton, Dickinson and Company, Boston Scientific Corp., Cantel Medical Corp., Conmed Corp., Cook group Inc. and others
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impact the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Gastrointestinal Stent Market Report by Segment
By Product type
By Technology Type
By Material
By end user
Global Gastrointestinal Stent Market Report by region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/gastrointestinal-stent-market